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Abstract
 
The thymus in mice lacking both the receptor tyrosine kinase c-kit and the common cytokine
receptor 
 
 
 
 chain (
 
 
 
c
 
) is alymphoid because these receptors provide essential signals at the earli-
est stages of thymocyte development. The signals transduced by these receptors potentially reg-
ulate proliferation, survival, or differentiation, but the contribution of each receptor to distinct
intracellular signaling cascades is only poorly defined. Here, we have examined whether en-
forced expression of Bcl-2 can rescue thymocyte development in c-kit and 
 
 
 
c
 
 single or double
mutant mice. A bcl-2 transgene (E
 
 
 
-bcl-2-25; expressed in the T cell lineage) was introduced
into (a) c-kit
 
 
 
and 
 
 
 
c
 
 wild-type (c-kit
 
 
 
 
 
c
 
 
 
bcl
 
 
 
), (b) c-kit–deficient (c-kit
 
 
 
 
 
c
 
 
 
bcl
 
 
 
), (c) 
 
 
 
c
 
-defi-
cient (c-kit
 
 
 
 
 
c
 
 
 
bcl
 
 
 
), or (d) c-kit and 
 
 
 
c 
 
double-deficient mice (c-kit
 
 
 
 
 
c
 
 
 
bcl
 
 
 
). The bcl-2
transgene was functionally active in wild-type and c-kit
 
 
 
or 
 
 
 
c
 
 single mutants, as it promoted
survival of ex vivo isolated thymocytes, including pro-T cells. In vivo, however, transgenic
Bcl-2 did not release T cell precursors from their phenotypic block and failed to increase pro-
genitor or total thymocyte cellularity in c-kit or 
 
 
 
c
 
 single or double mutants. These data argue
strongly against a role for Bcl-2 as a key mediator in signaling pathways linked to cytokine and
growth factor receptors driving early thymocyte development.
Key words: growth factors • c-kit • common cytokine receptor 
 
 
 
 chain • bcl-2 • T cell 
development
 
Introduction
 
Prothymocytes colonizing the thymus are very rare cells.
This small pool of thymic immigrants undergoes in the or-
der of 
 
 
 
100 fold (unpublished data) expansion before re-
arrangement of the TCR 
 
 
 
 chain. This expansion is medi-
ated by two key growth/cytokine receptors expressed on
prothymocytes, the tyrosine kinase c-kit and common cy-
tokine receptor 
 
 
 
 
 
chain (
 
 
 
c
 
)–IL-7R
 
 
 
 
 
chain complexes.
The ligands binding to these receptors, stem cell factor
(SCF) and IL-7, are provided by the epithelial thymic
stroma (for reviews, see references 1–3). In mutants lack-
ing c-kit and 
 
 
 
c
 
 together, but not in single c-kit– or 
 
 
 
c
 
-
deficient mice, the thymus is alymphoid, and TCR-
 
 
 
, -
 
 
 
,
and -
 
 
 
 rearrangements are essentially undetectable (4, 5).
Thus, c-kit and 
 
 
 
c
 
 provide essential, synergistic signals in
pro-T cells (for a review, see reference 2). Synergy be-
tween growth factor and cytokine signaling is a common
theme in many hematopoietic cells, including stem cells
(see, for example, reference 6). Due to the complete lack
of thymocytes, c-kit and 
 
 
 
c
 
 double mutant mice may pro-
vide a useful model in which individual signaling pathways
can be selectively rescued in vivo. At present, the down-
stream signaling pathways of each receptor are, at least in
primary thymocytes, only poorly defined.
Expression of the prototypic antiapoptotic protein Bcl-2
is developmentally regulated in thymocytes. Bcl-2 expres-
sion is high in immature CD3
 
 
 
CD4
 
 
 
CD8
 
 
 
 
 
(triple negative
[TN]) and mature CD3
 
 
 
CD4
 
 
 
CD8
 
 
 
 
 
or CD3
 
 
 
CD4
 
 
 
CD8
 
 
 
 (single positive [SP]), and is downmodulated in in-
termediate CD3
 
low
 
CD4
 
 
 
CD8
 
 
 
 
 
(double positive [DP]) thy-
mocytes (7, 8). Bcl-2 expression is reduced in thymocytes
from mice lacking IL-7R
 
 
 
 (9), 
 
 
 
c
 
 (8), or IL-7 (10), and is
upregulated after exposure of thymocytes from IL-7–defi-
cient mice to IL-7 in vitro (1, 10). Hence, signaling via
IL-7R/
 
 
 
c
 
 can upregulate Bcl-2 expression in thymocytes.
Thymocyte development in bcl-2–deficient mice is normal
until early adult life (
 
 
 
4 wk of age) followed by a strongly
increased sensitivity to apoptotic stimuli affecting, among
other cell types, all stages of thymocytes and peripheral
lymphocytes (11–13). Similarly, fetal liver–derived T cell
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development is more Bcl-2 independent than bone mar-
row–derived T cell development (13). Collectively, Bcl-2
can act as an antiapoptotic factor in thymocytes, in particu-
lar during adult life. As early T cell development is cyto-
kine/growth factor dependent, it is of interest whether
growth factor withdrawal–induced thymocyte death can be
prevented by Bcl-2 expression. There are conflicting data
on the role of Bcl-2 for the rescue of T cell development is
the absence of IL-7R
 
 
 
/
 
 
 
c
 
 signaling. Transgene-driven
overexpression of Bcl-2 was reported to rescue T cell de-
velopment in IL-7R
 
 
 
 chain (9, 14) or 
 
 
 
c
 
 (8, 15) mutant
mice (for a review, see reference 1). In contrast, other groups
failed to observe a Bcl-2–mediated rescue of 
 
 
 
c
 
-deficient
thymocytes (16, 17; for a review, see reference 2).
SCF stimulation can provide antiapoptotic signals in he-
matopoietic cells. This survival signal may be relayed via
activation of phosphatidylinositol 3 (PI-3) kinase and Akt
kinase (for a review, see reference 18), but c-kit–induced
survival may also involve Bcl-2 expression (19). Given that
c-kit
 
 
 
 
 
c
 
 
 
 mice are completely devoid of thymocytes, we
reasoned that these mutants would be a very sensitive
model to reveal potential, even minor, effects of Bcl-2
downstream of c-kit and 
 
 
 
c
 
. In this paper, we show that the
bcl-2 transgene was functionally active, and efficiently pro-
moted survival of thymocytes, including the earliest T cell
progenitors ex vivo. In vivo, however, transgenic bcl-2 ex-
pression failed to release T cell progenitors, both in terms
of phenotype and cell numbers, from their developmental
block in all mutants tested. As our data, using postnatal day
5 old mutant mice, did not confirm other reports analyzing
adult 
 
 
 
c
 
-deficient bcl-2 transgenic mice (1, 8, 15), we ex-
tended our studies to large numbers of adult 
 
 
 
c
 
-deficient
mice with or without the bcl-2 transgene. Notably, thymus
cell numbers in adult 
 
 
 
c 
 
mutants without the bcl-2 trans-
gene showed considerable heterogeneity (ranging over two
logs), an observation pointing at a possible role for modifier
genes in the genetic background of the 
 
 
 
c 
 
mutants.
 
 
 
In line
with our analysis of neonatal 
 
 
 
c 
 
mutants, enforced expres-
sion of Bcl-2 also failed to rescue T cell development in
adult 
 
 
 
c
 
-deficient mice. Our study, therefore, challenges
the current view that enforced expression of Bcl-2 can res-
cue defects in thymocyte development caused by lack of
 
 
 
c
 
, and suggests that gene products other than Bcl-2 might
modulate signaling pathways linked to cytokine (IL-7) and
growth factor (SCF) receptors in early thymocyte develop-
ment in vivo.
 
Materials and Methods
 
Mice.
 
WB-kit
 
W/
 
 
 
 (20) (SLC), 
 
 
 
c
 
 
 
 (21), and E
 
 
 
-bcl-2-25
(22) (The Jackson Laboratory) were maintained under specific
pathogen free-conditions. C-kit and 
 
 
 
c 
 
single and double mutant
mice were bred as described (4), and crossed to E
 
 
 
-bcl-2-25
mice. Experiments involving c-kit mutant mice were performed
on postnatal day 5 old mice, as white spotting locus (W/W) mice
die within 10 d after birth (23). W mutant mice were phenotyped
by white skin color. Experiments on 
 
 
 
c
 
 mutants were done either
on postnatal day 5, or on adult 6–12-wk-old mice. 
 
 
 
c
 
 mutant
mice were genotyped by PCR on genomic DNA as described
(4). E
 
 
 
-bcl-2-25 mice (22) were genotyped by PCR on genomic
DNA using oligonucleotides amplifying the human bcl-2 gene
(5
 
 
 
 oligo: 5
 
 
 
-GGTCATGTGTGTGGAGAGCGTCA-3
 
 
 
) linked
to the SV40 polyA site (3
 
 
 
 oligo: 5
 
 
 
-GTTTCAGGTTCAGGG-
GGAGGT-3
 
 
 
) yielding a diagnostic DNA fragment of 
 
 
 
1 kb. In
addition, in some experiments, thymocytes were typed by West-
ern blotting using anti–human Bcl-2–specific antibodies (Santa
Cruz Biotechnology, Inc.).
 
Monoclonal Antibodies and Flow Cytometry.
 
The following
monoclonal antibodies were used for flow cytometric analyses:
Anti-“lineage” antibodies were 2C11 (CD3
 
 
 
), H129.19 (CD4),
53-6.7 (CD8
 
 
 
) (both from GIBCO BRL), M1/70.15 (Mac-1;
Caltag), Gr-1 (granulocytes), TER119 (red blood cells), DX-5
(NK lineage), B220 (B cells; all PE-labeled), biotinylated ACK-4
(c-kit), FITC-labeled 3C7 (CD25), Cy-Chrome–labeled Pgp-1
(CD44; all from BD PharMingen, unless otherwise indicated);
streptavidin-allophycocyanin (APC) (Molecular Probes) was used
as second step reagent. For FACS
 
®
 
 analysis, thymocytes were
stained with monoclonal antibodies at 5–10 
 
 
 
g/ml in PBS/5%
FCS for 15–30 min on ice and washed once in PBS/5% FCS.
Cell sorting and FACS
 
®
 
 analysis were done on FACStar™ and
FACSCalibur™, respectively (Becton Dickinson). Fluorescence
data are displayed as dot plots using CELLQuest™ software (Bec-
ton Dickinson).
 
Ex Vivo Survival Assay.
 
Total or cell sorter purified thy-
mocyte subpopulations were placed in normal cell culture me-
dium (DMEM plus 10% FCS plus 1 mM pyruvate plus 2 mM
glutamine plus 2   10 5 M  -mercaptoethanol) and cultured
without additional growth factors. At time points indicated in
Fig. 1, absolute numbers (or percentage of the starting popula-
tion) of viable cells were determined by cell counting and trypan
blue exclusion in a Neubauer counting chamber.
Results and Discussion
The E -bcl-2-25 Transgene Promotes Survival of c-kit and  c
Mutant Thymocytes Ex Vivo. To analyze whether enforced
expression of the bcl-2 transgene could promote survival of
thymocyte populations in c-kit or  c mutant mice, the E -
bcl-2-25 mouse line was crossed to c-kit and  c single and
double mutants. In the E -bcl-2-25 mouse line, transgene
expression is T lineage specific (22) with an early onset of
transgene expression at the CD3 CD4 CD8  stage of de-
velopment (24). Functional transgenic Bcl-2 expression can
be monitored by extended survival times of primary thy-
mocytes isolated ex vivo (24). To test whether the E -bcl-
2-25 transgene was functional in these growth factor recep-
tor mutants, total thymocytes from each strain were
cultured in normal cell culture medium, and, at various
times after initiation of the culture, numbers of viable cells
were determined (Fig. 1, A–C). The results from  c and
c-kit wild-type mice demonstrated, as expected, that cell
death of transgenic thymocytes was delayed by about 2 d
when compared with nontransgenic cells cultured in paral-
lel (Fig. 1 A). Bcl-2 also mediated in vitro survival of thy-
mocytes from  c (Fig. 1 B) or c-kit (Fig. 1 C) single mutant
mice. Due to the complete absence of thymocytes (see be-
low), the corresponding analysis could not be performed
in c-kit  c
  mice.1433 Rodewald et al. Brief Definitive Report
C-kit and  c play essential roles at the most immature
stages of T cell development defined by the phenotypes
CD25 CD44  (TN 1) and CD25 CD44  (TN 2) (4). In a
previous analysis of the E -bcl-2-25 transgenic mice line,
functional expression of the bcl-2 transgene was shown for
TN 1 cells (24) but c-kit expression was not used to iden-
tify pro-T cell within TN 1. The TN 1 population contains
c-kit  and c-kit  cells, and the pro-T cell activity resides
only in the c-kit  fraction (25). Therefore, we analyzed
bcl-2 transgene function in c-kit  TN 1 as well as in c-kit 
TN 2 cells by comparison of the ex vivo survival potential
of cell sorter–purified progenitors from wild-type and E -
bcl-2-25 transgenic mice. The results demonstrate that this
bcl-2 transgene clearly promoted survival of both c-kit 
TN 1 (Fig. 1 D) and c-kit  TN 2 (Fig. 1 E) cells in vitro.
Thus, the E -bcl-2-25 transgene is functional in all of these
growth factor receptor mutants, and, importantly, promotes
thymocyte survival at those stages, in which thymocyte de-
velopment is impaired due to lack of c-kit and  c.
These data confirm the findings of O’Reilly and col-
leagues (24) on the function of this bcl-2 transgene in TN
2 cells, and extend functional bcl-2 expression to the c-kit 
(pro-T cell fraction) within the TN 1 subset. Kondo et al.
(15) reported that the E -bcl-2-25 transgene was not
expressed in the earliest thymic precursors defined as
CD3 CD25 c-kit  (which would include c-kit TN 1
cells). However, our experiments clearly show that this is
not the case, as both c-kit  TN 1 and c-kit  TN 2 cells
from E -bcl-2-25 were markedly protected from growth
factor withdrawal–induced apoptosis. Collectively, the E -
bcl-2-25 transgene is functional at exactly those stages of
development which are affected by lack of SCF and IL-7.
Enforced Expression of Bcl-2 Does Not Normalize Thymus
Cellularity in Postnatal c-kit and  c Single and Double Mutant
Mice In Vivo. Given that the bcl-2 transgene was func-
tional in the relevant progenitor subsets, we next analyzed
the effect of the transgene on thymus cellularity of various
growth factor receptor mutants. Mice of eight different
genotypes were generated and analyzed: (a) wild-type mice
with (c-kit  c
 bcl ) or (b) without (c-kit  c
 bcl ) the
transgene, (c) mice deficient for c-kit with (c-kit  c
 bcl ),
or (d) without (c-kit  c
 bcl ) the transgene, (e) mice defi-
cient for  c  with (c-kit  c
 bcl ), or (f) without (c-
kit  c
 bcl ) the transgene, and, finally, mice deficient for
both c-kit and  c with (g) (c-kit  c
 bcl ) or (h) without
(c-kit  c
 bcl ) the transgene. In Fig. 2, thymocyte num-
bers are plotted for all individual mice of the indicated ge-
notypes. In total, 121 mice were analyzed (numbers of mice
for each group are indicated in Fig. 2). As null mutations in
c-kit (c-kitW/W) are lethal within 10 d after birth, these
analyses were done on day 5.
Thymocyte numbers are reduced  15-fold in  c single
and  6-fold in c-kit single mutants when compared with
wild-type mice (4). As shown in Fig. 2, and as reported
previously (22), the bcl-2 transgene did not increase the
total cell number in wild-type mice (Fig. 2 A). Notably,
there was no significant (for the statistical evaluation, see
the legend to Fig. 2) effect of the bcl-2 transgene on thy-
mocyte cellularity in  c single (Fig. 2 B) and c-kit single
(Fig. 2 C) mutants. Thus, enforced expression of bcl-2
does not rescue overall thymic cellularity caused by lack of
 c or c-kit. The thymus anlage in c-kit  c
  mice, lacking
lymphoid cells, is composed of disorganized thymic epi-
thelium (26) and thymic dendritic cells, the latter cell type
developing independently of these growth factor receptors
and any detectable pro-T cell compartment (27). Given
that thymocytes are undetectable in the double mutant
thymus, this “null base line mutant” should be very sensi-
tive to uncover even marginal effects of the bcl-2 trans-
gene, i.e., even a partial Bcl-2–mediated rescue should be
evident by the reappearance of thymocytes. However,
even in bcl-2 transgenic c-kit  c
  mice, thymocytes failed
to appear.
In the Adult Thymus, the Developmental Block Caused by  c
Deficiency Is Not Rescued by Transgenic Bcl-2. Given that
c-kit null mutations are lethal by postnatal day 10, all experi-
ments involving c-kit single and double mutants, including
the relevant control mice (Fig. 2), were performed on 5-d-
old mice. While these experiments were underway, other
investigators reported that bcl-2 transgenes, when bred onto
 c-deficient mice, rescued T lymphopoiesis, but not B or
NK cell development (15). Similarly, bcl-2 transgenes were
Figure 1. The bcl-2 transgene (E -bcl-2-25) is functional in T cell
progenitors in c-kit and  c mutant thymocytes. Nontransgenic (open
symbols) or E -bcl-2-25 transgenic (filled symbols) total thymocytes
from 5-d-old c-kit  c
  (A) or c-kit  c
  mice (B), or c-kit  c
  mice
(C), or cell sorter–purified progenitor subsets (CD3 CD4 CD8  [TN])
c-kit CD25-CD44  (TN 1) (D), or c-kit CD25 CD44  (TN 2) (E)
from 5-d-old c-kit  c
  mice were compared for their survival capacity
ex vivo. Each symbol represents an individual mouse for each genotype.
Thymocytes were placed in normal cell culture medium in vitro, and, at
indicated times after initiation of the culture, numbers of viable cells were
determined. The E -bcl-2-25 transgene is functional in all of these
growth factor receptor mutants, and, importantly, promotes thymocyte
survival at those stages, in which mutations in c-kit or  c impair thy-
mocyte development (TN 1 and TN 2). Due to the complete absence of
thymocytes in the combined absence of c-kit and  c, the corresponding
analysis could not be performed on c-kit  c
  mice.1434 Bcl-2 Does Not Substitute for c-kit and  c Signaling in Thymocytes
also reported to rescue thymocytes cellularity in IL-7R –
deficient mice (9, 14). The discrepancy between lack of res-
cue of the  c deficiency phenotype, in our hands, and rescue
by bcl-2 transgenes, reported by others, prompted us to an-
alyze whether a Bcl-2 effect was only evident in adult mice,
but not in postnatal mice. Therefore, the impact of the E -
bcl-2-25 transgene on thymocyte cellularity in adult  c-
deficient mice was analyzed. In Fig. 3, thymus cellularity is
compared between  c
  and  c
 bcl  mice. When thymus
cell numbers were analyzed in large numbers (n   25) of
 c
  mice, we surprisingly observed a wide range of cell
numbers spreading over more than two logs. This data set
suggests that  c
  mice fall into three groups: (a) mice with a
relatively mild phenotype ( 107 thymocytes), (b) mice with
an intermediate phenotype (between 106 and 107 thy-
mocytes), and (c) mice with the most severe phenotype (be-
tween 105 and 106 thymocytes). Of note, a similar distribu-
tion was found in  c
 bcl  (n   34) mice. As these mice, but
also mice examined by Kondo et al. (15), were on mixed
genetic backgrounds (here WB, C57Bl/6, Balb/c, and 129/
ola), it is possible that the penetrance of the  c
 mutation is
subject to modifier genes, reminiscent of phenotypic heter-
ogeneity in IL-7R mutants (28). Nevertheless, comparing
 c
  versus  c
 bcl  mice, both range and mean values were
overlapping and not significantly different. Thus, in our
hands, a functionally active bcl-2 transgene does not rescue
thymus cellularity in adult  c-deficient mice.
Failure of Transgenic bcl-2 to Release  c-deficient Postnatal
or Adult Pre-T Cells from Their Phenotypic Block at the
CD25 CD44 /  Stage. A genetic rescue of a develop-
mental block in the thymus should be evident by increased
cell numbers, and by a release from the phenotypic devel-
opmental block. For instance, introduction of a TCR  
chain into SCID or recombination activating gene (RAG)
mutant mice releases thymocytes from their block in differ-
entiation at the TN 3 stage, and promotes the development
of TN 4 cells and large numbers of CD4 CD8  thy-
mocytes (for a review, see reference 29). In mice lacking  c
or IL-7R  or IL-7, TN thymocyte development is severely
affected. The transition from TN 2 (CD44 CD25 ) to TN
3 (CD44 CD25 ) stages is (incompletely) blocked causing
increased percentages of TN 2 and decreased percentages of
TN 3 cells (30, 31). As a result of this block, TN 4
(CD44 CD25 ) cells are reduced  10-fold in  c/IL-7R /
IL-7 mutants (for a review, see reference 2). To test the
possibility that such “phenotypic release” took place with-
out affecting overall cell numbers (Figs. 2 and 3), lineage
marker (CD3, CD4, CD8, B220, Ter119, Mac 1, Gr-1,
DX5)-negative thymocytes were analyzed by flow cytome-
try for expression of CD44 versus CD25 (Fig. 4). This anal-
ysis included postnatal 5-d-old (Fig. 4, A–C) and adult (Fig.
4, D–F) mice which had a wild-type (Fig. 4, A and D),  c-
deficient (Fig. 4, B and E), or  c-deficient bcl-2 transgenic
(Fig. 4, C and F) genotype. In agreement with previous re-
Figure 2. Failure of trans-
genic Bcl-2 to normalize thy-
mocyte cellularity in c-kit and
 c single and double mutant
mice in vivo. To asses the effect
of transgenic Bcl-2 expression
on thymus cellularity in growth
factor receptor mutants, mice of
eight different genotypes were
generated: (A) wild-type mice
without (c-kit  c
 bcl ;   ) or
with (c-kit  c
 bcl ;   ) the
transgene; (B) mice deficient for
 c  without (c-kit  c
 bcl ;   )
or with (c-kit  c
 bcl ;  ) the
transgene; (C) mice deficient for
c-kit without (c-kit  c
 bcl ;
 ) or with (c-kit  c
 bcl ;   )
the transgene; (D) mice defi-
cient for both c-kit and  c with-
out (c-kit  c
 bcl ;  ) or with
(c-kit  c
 bcl ;   ) the trans-
gene. All mice were analyzed on
postnatal day 5 because c-kitW/W
mice die by postnatal day 10.
Numbers of mice per group are
indicated above each group; be-
low, the mean cell number   1
SD are shown. No significant
differences were observed be-
tween bcl-2 transgenic and non-
transgenic mice (Wilcoxon rank-sum test: A: transgenic vs. nontransgenic, rank-sum normal statistic with correction Z    0.8997, P value   0.3683;
B: transgenic vs. nontransgenic, rank-sum normal statistic with correction Z    1.645, P value   0.1; C: transgenic vs. nontransgenic, rank-sum nor-
mal statistic with correction Z    1.0839, P value   0.2784, alternative hypothesis: true   is not equal to 0; in D, no statistical comparison was done
because thymocytes were undetectable in both groups of mice). Thymocytes were undetectable in c-kit  c
  mice regardless of the bcl-2 transgene.1435 Rodewald et al. Brief Definitive Report
ports (30, 31), data shown in Fig. 4 confirmed that the tran-
sition from TN 2 to TN 3 was inhibited, and that TN 4
cells were almost absent in postnatal ( c
 : 16% TN 2, 63%
TN 3, and 14% TN 4, versus  c
 : 42% TN 2, 36% TN 3,
and 1% TN 4), and in adult ( c
 : 11% TN 2, 63% TN 3,
and 21% TN 4, versus  c
 : 40% TN 2, 57% TN 3, and 1%
TN 4)  c
  mice. A release from the “ c block” should be
detectable by decreased percentages of TN 2, increased per-
centages of TN 3, and, most visibly, by rescue of the lack-
ing TN 4 compartment. Notably, the pattern of TN subsets
was unaltered comparing  c
  and  c
 bcl  mice. This holds
true for both young (Fig. 4, compare B versus C) and adult
(Fig. 4, compare E versus F) mice.
In addition to the overall reduction in thymocyte cellu-
larity, cell numbers of lineage marker–negative thymocytes
are also reduced in  c
  mice (for a review, see reference 2).
To analyze lin  cell numbers in these mutant mice,
CD4 CD8  (DN) thymocytes were prepared (by  CD4
and  CD8 antibody binding and C  lysis), and the resulting
populations were stained with the lineage-mix antibodies
(see above). In postnatal  c
  mice, the DN population con-
tained 43% lin  cells (which split into TN 1 to 4 subsets as
shown in Fig. 4). In contrast, in postnatal  c
  mice, the DN
population contained only 27% lin  cells, demonstrating an
overall reduction in thymic lin  cellularity of  30-fold
(15-fold reduction in overall thymocyte cell numbers and
2-fold reduction of lin  cells). The proportion of thymic
lin  cells among DN thymocytes was strongly reduced in
adult mice compared with young mice (young  c
  mice:
43% lin  cells; adult  c
  mice: 7.8% lin  cells). Of note, the
proportion of thymic lin  cells among DN thymocytes was
not increased by Bcl-2 (postnatal mice:  c
    43%;  c
   
27%;  c
 bcl  25% lin  cells; adult mice:  c
    7.8%;
 c
     4.4%;  c
 bcl  3.1% lin  cells). Collectively, en-
forced expression of Bcl-2 failed to rescue the phenotypic
block in  c
  mice, and did not increase the lin  thymic pro-
genitor pool. This finding is consistent with the observed in-
ability of Bcl-2 to rescue overall thymus cell numbers.
In two previous reports suggesting that transgenic bcl-2
can rescue T cell development in  c
  mice (8, 15), the phe-
notype of TN subsets, according to CD44 versus CD25
staining on lineage-negative thymocytes, had not been in-
vestigated. Kondo et al. analyzed progenitor populations
Figure 3. Failure of transgenic bcl-2 to rescue thymus cellularity in
adult  c-deficient mice in vivo. To analyze the effect of transgenic bcl-2
expression on thymus cellularity in adult mice, animals of four different
genotypes were generated: (A) wild-type mice without (c-kit  c
 bcl ;
 ) or with (c-kit  c
 bcl ;  ) the transgene, and (B) mice deficient for  c
without (c-kit  c
 bcl ;  ) or with (c-kit  c
 bcl ;  ) the transgene.
Null mutations in c-kit (W/W) are lethal by postnatal day 10 precluding
an analysis of adult c-kit–deficient mice. Numbers of mice per group are
indicated above each group; below, the mean thymocyte cell number   1
SD are shown. Although the range of cell numbers per thymus was very
large (over two logs), no differences were observed between bcl-2 trans-
genic and nontransgenic mice.
Figure 4. Failure of transgenic bcl-2 to release postnatal or adult pre-T
cells from their  c dependence at the CD44 / CD25  stage.  Lineage
marker (CD3, CD4, CD8, B220, Ter119, Mac 1 Gr-1, DX5) negative
thymocytes from postnatal day 5 (A–C) or adult (D–F)  c
 wild-type (A and
D),  c
  (B and E), or  c
 bcl  (C and F) mice were analyzed by flow cy-
tometry for expression of CD44 vs. CD25. Thymocytes develop from TN
1 (CD44 CD25 ) via TN 2 (CD44 CD25 ) and TN 3 (CD44 CD25 )
to TN 4 (CD44 CD25 ). In  c
  mice, thymocyte development is in-
completely blocked at the transition from TN 2 to TN 3 causing a strong
reduction in TN 4 cells (14% [postnatal] or 21% [adult] TN 4 in  c
 wild-
type vs. 1% [for both postnatal or adult] TN 4 in  c
 ). Enforced expression
of Bcl-2 does not release postnatal or adult thymic precursors from the de-
velopmental block caused by lack of  c (compare B vs. C, and E vs. F).1436 Bcl-2 Does Not Substitute for c-kit and  c Signaling in Thymocytes
for expression of c-kit versus CD25 gated on CD3  cells,
an analysis which may have obscured phenotype and distri-
bution within TN subsets because many other nonprogen-
itor cells types such as NK cell or myeloid cells are included
in the CD3  cells. Clearly, failure of a Bcl-2–mediated res-
cue of the strongest  c
  phenotype, i.e., restoration of TN
4 cells, cannot be detected by this type of analysis. Pheno-
typic and quantitative analysis of the TN 1 to 4 subsets in
 c
  mice now demonstrates that enforced expression of
Bcl-2 does not rescue the  c- mutant phenotype.
Growth Factor– and Cytokine Receptor–mediated Signals Are
Essential at the First Stages of Thymocyte Development: A Role
for Bcl-2? Thymocyte development can be separated into
three major stages: (a) growth factor– and cytokine-driven
expansion of rare colonizing T cell progenitors; (b) selec-
tion of thymocytes for further development on the basis of
productive TCR   chain/pre-TCR complexes ( -selec-
tion); and (c)  /  TCR–based repertoire selection. In this
first expansion, c-kit and  c act in synergy, i.e., each recep-
tor mutant alone is permissive for T cell development but
mice lacking both receptors lack all thymocytes. The mo-
lecular mechanisms underlying this signaling synergy in
thymocytes are unknown. Clearly, one or both of these re-
ceptors may induce an intracellular antiapoptotic signal.
In this paper, we have analyzed bcl-2 transgenic young
c-kit and  c single and double mutants, as well as adult  c
mutants. Enforced expression of Bcl-2 (a) failed to increase
thymocyte cell numbers, and (b) TN 2/TN 3 cells were
not released from their block in differentiation. To account
for possible variability within each group of mice, large
numbers of animals were analyzed, both for young and
adult mice. Consistent with our finding that Bcl-2 expres-
sion cannot overcome defects in c-kit  thymocytes, Do-
men and Weissman showed that development of mast cells,
a c-kit–dependent lineage, was not rescued by expression
of transgenic bcl-2 in viable c-kit mutants (W41/W41) (6).
In stem cells, Bcl-2 has been suggested to synergize with
c-kit signaling in preventing cell death but here, as in early
thymocytes (this study), Bcl-2 does not act downstream of
c-kit (6).
The effect of bcl-2 transgenes on the thymus in  c-defi-
cient mice, has been studied by us (this paper) and others
(8, 15), and the results are clearly conflicting. Kondo et al.,
crossed the very same bcl-2 transgenic line (E -bcl-2-25)
into  c-deficient mice, and reported partial rescue of thy-
mocyte cell numbers (6.8   106 [ c
 ] vs. 2.8   107 [ c
 
E -bcl-2-25]). Although these authors observed almost no
effect of the bcl-2 transgene on the precursor pool (defined
as CD3  c-kit ), the increase in cell numbers was some-
what stronger in more mature thymocytes (defined as
CD69  cells). We cannot reproduce the findings by Kondo
et al. on overall cellularity, and have no evidence that bcl-2
expression can release  c-deficient thymocytes from their
phenotypic block (Fig. 4). This discrepancy is not easily ex-
plained. One caveat in this type of genetic rescue experi-
ment by crossing mouse lines is based on the fact that  c
deficiency appears to be sensitive to modifier genes, and
mice used in our study, but also mice used by others, were
on mixed genetic backgrounds (only three backcrosses to
B6 [15], or two backcrosses to B6 or Balb/c [8]). As we
observed a massive heterogeneity of cell numbers ranging
over two logs which became evident only after analysis of
large numbers of mice (Fig. 3), such heterogeneity might
account for the observed discrepancies. A detailed analysis
of the developmental block in  c-mutants with “mild” ver-
sus “intermediate” versus “severe” reduction in thymus cell
numbers could give insights into the nature of any modifier
gene(s). Enforced Bcl-2 expression may “tilt” death versus
differentiation choices constantly towards survival along
various intra- and extrathymic T cell differentiation stages,
causing “nonspecific” accumulation of thymocytes. Never-
theless, we conclude that a Bcl-2–mediated survival signal
is insufficient to substitute for the stage-specific signals pro-
vided by c-kit and  c in prothymocyte development.
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